Skip to main content
Livermore
Livermore
ZHEN

Rafferty Asset Management, LLC

SEC CIK
0001389426
Latest filing
Aug 14, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Rafferty Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
3,643
Value
$204.3K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of RPRX by Rafferty Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,643$204.3K<0.1%+3,643NewHolders
Q1 20260$00.0%−6,112−100.0%Sold outHolders
Q4 20256,112$236.2K<0.1%+135+2.3%AddedHolders
Q3 20255,977$210.9K<0.1%−1,003−14.4%ReducedHolders
Q2 20256,980$251.5K<0.1%−2,943−29.7%ReducedHolders
Q1 20259,923$308.9K<0.1%−4,156−29.5%ReducedHolders
Q4 202414,079$359.2K<0.1%−1,748−11.0%ReducedHolders
Q3 202415,827$447.7K<0.1%+847+5.7%AddedHolders
Q2 202414,980$395.0K<0.1%−1,722−10.3%ReducedHolders
Q1 202416,702$507.2K<0.1%+2,365+16.5%AddedHolders
Q4 202314,337$402.7K<0.1%+1,737+13.8%AddedHolders
Q3 202312,600$342.0K<0.1%+2,841+29.1%AddedHolders
Q2 20239,759$300.0K<0.1%+1,798+22.6%AddedHolders
Q1 20237,961$286.8K<0.1%+866+12.2%AddedHolders
Q4 20227,095$280.4K<0.1%+1,468+26.1%AddedHolders
Q3 20225,627$226.0K<0.1%−229−3.9%ReducedHolders
Q2 20225,856$246.0K<0.1%−5,553−48.7%ReducedHolders
Q1 202211,409$444.0K<0.1%−11,524−50.3%ReducedHolders
Q4 202122,933$914.0K<0.1%+3,016+15.1%AddedHolders
Q3 202119,917$720.0K<0.1%+8,704+77.6%AddedHolders
Q2 202111,213$460.0K<0.1%+3,060+37.5%AddedHolders
Q1 20218,153$356.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.